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1991). This light-dependent step involves the expression of certain gamete-specific genes, such as gas28 (Treier and Beck, 1991; Von Gromoff and Beck, 1993) . This step can be inhibited by treatment with the protein-synthesis inhibitors cycloheximide and anisomycin. The absolute requirement for light allowed us to screen for mutants that undergo gametogenesis in the dark (Buerkle et al., 1993) . Three of these mutations induce light-independent expression of gamete-specific genes; they are recessive and genetically closely linked (Gloeckner and Beck, 1995) . Apparently, a block in the progression of gametogenesis can be removed by altering one of the components in the signaling cascade. We reasoned that we might be able to identify components of the signaltransduction chain by using well-characterized inhibitors and/or activators of signaling proteins. This approach proved effective in the analysis of phytochromemediated responses (Neuhaus et al., 1993; Bowler et al., 1994a) . Because C. reinhardtii is known to respond to many pharmacological agents used in signal-transduction research (Pasquale and Goodenough, 1987 ; for reviews, see Musgrave, 1993; Quarmby, 1994) , we analyzed their effect on its pregamete-to-gamete conversion. The results obtained allow us to propose a signaling chain regulating this process.
MATERIALS A N D M E T H O D S Strains and Culture Conditions
Chlamydomonas reinhardtii wild-type strain CC124 (mt-) was used as the tester strain that was treated with the pharmacological agents. CF14 (mt+), a sibling from a cross between CClOlO (mt+) and 137c (mt-) , served as the mating partner. Cells were inoculated from TAP plates (up to 1 week old) directly into 250-mL Erlenmeyer flasks containing 50 mL of TAP medium (Harris, 1989) . Cultures were incubated at 23°C on a rotary shaker (120 revoluAbbreviations: 8-Br-cGMP, 8-bromo-cyclic 3'5' guanosinemonophosphate; db-cAMP, dibutyryl-cyclic 3'5' adenosinemonophosphate; IBMX, 3-isobutyl-1-methylxanthine; PKC, protein kinase C; PMA, phorbol-12-myristate 13-acetate; SC-9, N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide; SC-10, N-heptyl-5-chloro-lnaphthalenesulfonamide; TAP, Tris-acetate-phosphate; TAP-N, TAP medium without nitrogen. 303
Plant Physiol. Vol. 112, 1996 tions/ min) under continuous white light (14 W / m2 provided by fluorescent tubes (L36W/25, Osram, Munich, Germany). The final cell density was approximately 1 X 107 cells/mL.
Reagents
All pharmacological compounds were prepared as stocks and stored at -70°C in the dark unless recommended otherwise. Tyrphostin 51 and LY83583 were dissolved in ethanol, microcystin LR was dissolved in methanol, and papaverine was dissolved in water. Other compounds were dissolved in DMSO when an organic solvent was required, or in TAP-N (the information was obtained from the providing companies). After dilution, the final concentration of the organic solvent was less than 0.2%, which did not interfere with gametogenesis or mating. db-cAMP, 8-Br-cGMP, 5'AMP, papaverine, 3-isobutyl-l-methylxanthine, Zaprinast, Tyrphostin 51, orthovanadate sodium, Mastoparan, and chelerythrine were purchased from Sigma. Suramine sodium, PMA, SC-9, and N-acetyl-S-farnesyl-L-Cys were obtained from Biomol (Dianova, Hamburg, Germany). LY83583, Calyculin A, SC-10, calmidazolium, cholera toxin, pertussis toxin, Microcystin-LR, KN-62, K252a, genistein, Rapamysin, staurosporine, and okadaic acid were obtained form Calbiochem-Novabiochem (Bad Soden, Germany).
Cametogenesis Assays
Vegetative C. reinhardtii cultures of strains CC124 and CF14 were resuspended in TAP-N at densities of 1.2 X 107 and 1.4 X 107 cells/mL, respectively. Mature CF14 gametes were obtained by incubating 30-mL cultures with continuous illumination (14 W/m2) for 16 h. For gametogenesis assays of the tester strain CC124, three treatments were performed. The first (mating control) was to generate mature gametes in TAP-N with continuous illumination for 13.5 h (30-mL cultures). Aliquots of 100 pL were pipetted into the wells of microtiter plates, and the reagents were then added to the wells and incubated for another 2.5 h in the light before testing the mating competence. The second treatment (pregamete-to-gamete conversion) was to generate pregametes in 30-mL cultures by incubating them in the dark in TAP-N for 13.5 h. Aliquots (100 pL) were transferred to a microtiter plate, reagents were added, and cells were then incubated for 30 min in the dark before illuminating them for 2 h. During the third treatment (dark activation) cells were kept in continuous dark before testing their mating competence.
Determination of Mating Competence
After treating cells, an equal volume of mating partner CF14 was added and mating was allowed to proceed in the dark for 30 min. Cells were then fixed by adding glutaraldehyde (final concentration, 0.5%), and the percentage of quadriflagellate cells was microscopically determined. Three hundred cells were counted for each sample. The percentage of mating was calculated using the following equation:
where QFC = quadriflagellate cells, A = cell number of the tester strain divided by the total number of cells in the mating mixture, and BFC = the number of biflagellate cells (Beck and Acker, 1992) . Results are presented as the mean of at least three experiments, with the calculated SE.
RESULTS

Pregamete-to-Camete Conversion Assay
We limited our investigations to the light-controlled conversion of pregametes to gametes because this second step in gametic differentiation is completely blue-lightdependent (Weissig and Beck, 1991) . In addition, it is complete within a few hours (Treier et al., 1989; Beck and Acker, 1992) and can be expected to proceed synchronously. The assay relies on the formation of zygotes in a mixture of the treated tester strain and the untreated partner. In compaiison with other gametogenesis assays, which determine the activation of agglutinins (Adair et al., 1982) or the amount of gamete lytic enzyme (Matsuda et al., 1978) , we have assayed acquisition of mating competence, which enabled us to quantify the process. However, it meant that we had to check every component for an effect on agglutination and zygote formation. As described in "Materials and Methods," we routinely compared three treatments of the tester strain: (a) a control treatment to test for effects on zygote formation in the light, (b) a conversion assay to test for effects on light-dependent gametogenesis, and (c) a dark treatment to test for the activation of gametogenesis in the absence of a light signal. The necessity of a control treatment is illustrated by the data in Table I ; many compounds interfered with zygote formation, either directly or simply by causing deflagellation (which makes it impossible for gametes to recognize each other). Most components were tested at O.lx, l x , 5x, and 1OX the concentration that has previously been shown to be effective in mammalian or plant cell systems (Sheen, 1993; Felix et al, 1994) .
lnhibition of Light-Dependent Cametic Differentiation: The Effects of Cenistein, db-cAMP, and Papaverine
Treatment of pregametes with the protein Tyr kinase inhibitor genistein inhibited their conversion to mature gametes in the light in a concentration-dependent manner without affecting the mating ability of mature gametes ( Fig. 1 ). Other protein kinase inhibitors such as K252a, KN-62, and the Tyr kinase inhibitor Tyrphostin 51 were ineffective; therefore, the effect of genistein on pregameteto-gamete conversion appears to be specific. The effective concentration of genistein (50-300 p~) is in accordance with values reported for other plant-cell systems (Bowler et al., 1994b) . C. reinkardtii gametes are known to be activated by treatment with cyclic AMP (Pasquale and Goodenough, 1987; Goodenough, 1989) . In our assay, db-cAMP treatment did not influence the relative percentage of mating, but it did inhibit pregamete-to-gamete conversion in the light ( Fig.  2A) . Similarly, when we tried to achieve an increase in the intracellular cAMP concentration by treatment with the phosphodiesterase inhibitor papaverine, we found that it specifically inhibited pregamete-to-gamete conversion (Fig. 2B) . Increasing the papaverine concentration to 200 p~ completely inhibited pregamete-to-gamete conversion, whereas there was no significant reduction of zygote formation in the control treatment. Combining db-cAMP treatment with papaverine enhanced this inhibitory effect (Fig. 2C) , indicating that papaverine indeed increased the intracellular cAMP concentration. These data suggest that cAMP negatively regulates the progression of gametic differentiation in the light.
Activation of Gametogenesis in the Dark: A PKC-Like Component May Attenuate the Light-Dependent
Step in Gametogenesis
Protein kinase inhibitors either had no effect on pregameteto-gamete conversion or, in the case of staurosporine, chelerythrine, and H89, they prevented zygote formation (see Table I ). However, since we also tested compounds for the activation of gametogenesis in the dark, we discovered that treatment with low concentrations of staurosporine resulted in pregamete-to-gamete conversion in the dark (Fig. 3A) . Concentrations ranging from 10 to 50 nM were effective, whereas higher concentrations inhibited zygote formation. Maximum activation in the dark resulted in a conversion of approximately 8%. We reasoned that if inhibition of a PKClike component could initiate pregamete-to-gamete conversion in the dark, activators of PKC should block light-dependent gametogenesis. Treatment of pregametes with the phorbol ester PMA, an activator of PKC (Huang, 1989) , inhibited zygote formation by as much as 40% without affecting the mating competence of mature gametes in the light (Fig. 3B) . The naphthalene sulfonamides SC-9 and SC-10 also activate PKCs (Ito et al., 1986) and, again, specifically inhibited the pregamete-to-gamete conversion (Fig. 3C) . SC-10 was more effective (inhibitor concentration for 50% displacement = 8 p~) than SC-9 (inhibitor concentration for 50% displacement = 100 p~) and could almost completely prevent gametogenesis at 200 p~ without a significant effect on zygote formation. These data suggest that a PKC-like component may be involved in attenuating the lightdependent step in gametic differentiation of C. reinkardtii.
Similarly, we discovered that treatment of pregametes with papaverine promoted gametogenesis in the dark, even though it had an inhibitory effect in the light (Fig. 4) . Low concentrations of papaverine (2 p~) already caused pregamete-to-gamete conversion in the dark, with a maximum of approximately 6%. Similar to what we found for papaverine, a dark-activation effect of db-cAMP was also discovered (data not shown). This dark activation was not as reproducible as the papaverine and staurosporine effects and varied between 2% (for 20 mM db-cAMP) and 4% (for 4 mM db-CAMP).
Ordering the Effective Components: Combined Treatments
If one assumes that a linear signaling pathway is involved in transducing the light signal, one can predict that nent. Treatment with 20 mM db-cAMP reduced the staurosporine-induced activation to a level equal to the darkactivation effect of cAMP alone. Surprisingly, combining papaverine (50 p~, treatment E) and staurosporine increased the level of activation to a maximum of 15%. This suggests that these compounds work synergistically.
DlSCUSSlON
Studying gametogenesis in a lower plant such as the green alga C. veinhavdtii has the advantage that one can obtain large quantities of cells that differentiate synchronously. We selected strains that had no capacity to form gametes in the dark, because some strains were leaky for this phenotype. These strains were used to design an assay suitable for testing the effect of pharmacological compounds on the light-dependent step in gametogenesis. Many pharmacological compounds tested influenced the mating reaction (Table I ) and thereby masked the effects they could have had on the progression of gametogenesis. For instance, the involvement of G-proteins, which are known to be key players in phototransduction (Bowler et al., 1994a; Yarfitz and Hurley, 1994) , could not be evaluated.
Compounds that activate G-proteins caused deflagellation, and inhibitors of G-proteins inhibited mating. These agents are candidates for assays in which the activation of the sexual agglutinins (Adair et al., 1982 ) is used as a measure of maturation of pregametes. Although more laborious and semiquantitative, it would still allow statements about the effect of these compounds on the bluelight-controlled step in gametogenesis, especially in combination treatments.
The data that we gathered have been summarized in a model (Fig. 6 ). Our first assumption is that blue light feeds into a linear signal chain that induces the gene expression necessary for differentiation of pregametes to gametes. This is based on the observation that a11 mutants that exhibit light-independent gametogenesis show a lightindependent expression of gamete-specific genes (Buerkle et al., 1993; Gloeckner and Beck, 1995) . Apparently, many components of t h e C. reinkardtii blue-light-signaling c h a i n act as negative regulators, a situation that is similar to that in the higher plant Arabidopsis, in which the photomorphogenesis mutants det and cop are affected in components involved in negative regulation (Bowler et al., 1994a) . We propose that a PKC-like component is involved in attenuating the transduction of the light signal, since staurosporine at concentrations specific for PKC inhibition (5-50 nM) can induce activation in the dark. To explain the activation in the absence of a signal (light), we propose a low basal flux through this signaling cascade. The low level of activation achieved by inhibiting the attenuator is then exsc-9. sc-10, PMA Vol. 112, 1996 plained by assuming that the basal flux through the signaling chain is not enough to achieve differentiation in all cells. The concept of a basal flux going through a signaling chain has been postulated for signaling pathways in higher plants (Bowler and Chua, 1994) . The suggestion that a "PKC-like" component is involved in attenuating gametogenesis is supported by the inhibitory action of agents that are known to stimulate PKC activity (SC-9, SC-10, and PMA; Fig. 3, B and C) . If we take the results of Zhang and Snell (1994) into account, which suggest that 1 PM staurosporine can activate flagellar adenylate cyclase in vitro, our findings could also be explained by stating that the mating reaction in the dark is stimulated by staurosporine, allowing pregametes to differentiate into gametes in the dark. However, when the dark-activation experiments were performed in the presence of the protein synthesis inhibitor anisomycin (0.25 mM), we could not detect any activation (results not shown). This suggests that staurosporine activates a part of the cascade that induces gamete-specific gene expression (Treier and Beck, 1991) and not matingassociated processes.
The effect of genistein, inhibition of light-and staurosporine-induced activation, points to a protein Tyr kinase further downstream in the signaling cascade (Fig. 6) . The presence of a genistein-sensitive component at the end of a light-dependent signaling cascade has been reported previously (Bowler et al., 1994b) . In that case genistein inhibited the induction of the chalcone synthase gene expression. It remains to be determined whether the expression of gamete-specific genes in C. reinkardfii is influenced by genistein.
The effect of db-cAMP on the conversion of pregametes to gametes in the light was inhibitory, and this was corroborated by a similar effect of the phosphodiesterase inhibitor papaverine. This fits nicely with experiments performed with Chlamydomonas eugumetos, in which Kooijman et al. (1990) have shown that cAMP levels decrease when dark-inactivated gametes are illuminated and become active. Sustaining a higher leve1 of cAMP by adding it exogenously would thus block activation. Although cAMP was capable of blocking the activating effect of staurosporine, suggesting that it worked downstream in the signaling cascade, papaverine treatment enhanced the activating effect. Although papaverine alone could induce dark activation, the increase achieved by combining it with staurosporine was more than 6%, indicating that these two compounds work synergystically. This gives support to the idea that the basal flux through the signaling chain is low and needs additional stimulation to achieve higher levels of activation. One explanation for the observed difference between the effects of papaverine and cAMP is that papaverine not only influences phosphodiesterase activity, but it has a second target with a different function in the signal pathway. Indeed, suggestions that papaverine might influence the intracellular calcium concentration directly or indirectly through cGMP can be found in the literature (Sgaragli et al., 1993) . However, we were unable to record the effects of compounds that induce an increase in the intracellular calcium concentration, because these treatments caused deflagellation of the pregametes, disabling our assay system. Similarly, 8-BrcGMP and zaprinast could not be evaluated because they interfered with mating in mature gametes (Table I) . Additional work will concentrate on the effects of pharmacological agents on the expression of gamete-specific genes and on changes in protein phosphorylation during the light-dependent step. Together with the analysis of the mutant strains, this approach should allow us to identify some of the key components in the blue-light signaling chain that controls gametogenesis.
